The auction for the assets, including popular malt-based health drinks brands Horlicks and Boost, could fetch more than $4 billion, sources told Reuters previously.
Nestle, Unilever in pole position for GSK’s Indian Horlicks business
More from Industry NewsMore posts in Industry News »
- Frontline, medical workers need to take booster shots, say experts
- India tells Quad will allow export of 8 mln Indo-Pacific vaccine doses
- We need to be vigilant towards counterfeit products: Nakul Pasricha,President, ASPA
- India tops the chart for approved biosimilars and clinical trials surpassing USA and Europe: 10th Annual Pharma IPR India Conference